Dr. Paulovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 Fairview Avenue N.
Seattle, WA 98109Phone+1 206-667-1912
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2004
Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2000
University of Washington School of MedicineClass of 1998
Certifications & Licensure
WA State Medical License 2004 - 2025
MA State Medical License 2002 - 2005
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- 2 citationsNeoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin
Cancer Cell. 2024-11-11 - CDK5-cyclin B1 regulates mitotic fidelity.Xiao-Feng Zheng, Aniruddha Sarkar, Humphrey Lotana, Aleem Syed, Huy Nguyen
Nature. 2024-09-01 - Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry.Jeffrey R Whiteaker, Lei Zhao, Regine M Schoenherr, Dongqing Huang, Jacob J Kennedy
Scientific Data. 2024-06-25
Press Mentions
Combination Therapy Shows Promising Results in Treating Stage 3 MelanomaOctober 31st, 2024- Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, BiomarkersNovember 25th, 2020
- First Large-Scale Proteogenomic Analysis Offers Insights into Pediatric Brain TumorsNovember 25th, 2020
- Join now to see all
Grant Support
- Proteo-Genomic Discovery, Prioritization And Verification Of Cancer BiomarkersNational Cancer Institute2011
- Population-Based Study Of DNA Damage Response Markers Of Prognosis In Breast CancNational Cancer Institute2010–2011
- Minimizing Mass Panic With Saliva Tests For Radiation ExposureNational Institute Of Allergy And Infectious Diseases2008–2011
- Cross-Species Network Approach To Predict Epistatic Cancer Susceptibility GenesNational Cancer Institute2008–2011
- Phenotype-Based Approach To FIND Gene Interactions Underlying Breast Cancer RiskNational Cancer Institute2007–2011
- Measurement Of Cancer-Associated Biomarker Proteins In Complex Biological SamplesNational Cancer Institute2009–2010
- Protein Biomarker DosimetryNational Institute Of Allergy And Infectious Diseases2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
